Trial site
Banner MD Anderson Cancer Center
- 96running trials
- 39closed trials
The trials here
What the 138 trials at this site are about, from their registry records.
- Conditions
- Lung cancer17 trials
- Head and neck cancer15 trials
- Multiple myeloma15 trials
- Bladder cancer11 trials
- Metastatic breast cancer11 trials
- Colorectal cancer10 trials
- Melanoma10 trials
- Acute myeloid leukaemia9 trials
- Pancreatic cancer9 trials
- Prostate cancer7 trials
- Childhood cancers6 trials
- Chronic lymphocytic leukaemia5 trials
- and 22 more
- Phase
- Phase 356 trials
- Phase 231 trials
- Phase 1/224 trials
- Phase 114 trials
- Phase 2/34 trials
- Status
- Active, not recruiting50 trials
- Recruiting39 trials
- Completed24 trials
- Terminated13 trials
- Not yet recruiting4 trials
- Enrolling by invitation3 trials
- Suspended3 trials
- Withdrawn2 trials
- Lead sponsor
- National Cancer Institute (NCI)14 trials
- SWOG Cancer Research Network7 trials
- Janssen Research & Development, LLC6 trials
- NRG Oncology6 trials
- Kite, A Gilead Company5 trials
- and 69 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
Active, not recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Recruiting
Recruiting
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Active, not recruiting
Recruiting
Recruiting
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Active, not recruiting
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 96.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer5 recruiting
- Colorectal cancer5 recruiting
- Lung cancer5 recruiting
- Melanoma5 recruiting
- Multiple myeloma5 recruiting
- Acute myeloid leukaemia4 recruiting
- Childhood cancers4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Head and neck cancer3 recruiting
- Kidney cancer3 recruiting
- Metastatic breast cancer3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Prostate cancer3 recruiting
- Chronic myeloid leukaemia2 recruiting
- Neuroendocrine tumours2 recruiting
- Pancreatic cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aplastic anaemia1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Testicular cancer1 recruiting
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Withdrawn
Completed
Terminated
Completed
Terminated
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Terminated
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Terminated
Terminated
Terminated
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Completed
Completed
Completed
Completed
Recruiting
Terminated
Terminated
Completed
Recruiting
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Completed
Completed
Terminated
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
Completed
Terminated
Completed
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
Completed
Completed
Completed
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Completed
Completed
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Completed
Completed
Completed
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Site data: ClinicalTrials.govUpdated 17 Nov 2026